Last $0.10 USD
Change Today -0.0099 / -9.00%
Volume 10.0K
VYST On Other Exchanges
As of 12:36 PM 07/23/14 All times are local (Market data is delayed by at least 15 minutes).
text size: T | T
Back to Snapshot
Company Description

Contact Info

Building 400

Suite 290

3235 Satellite Boulevard

Duluth, GA 30096

United States

Phone: 770-965-0383

Fax: 770-965-0162

Vystar Corporation focuses on producing Vytex Natural Rubber Latex (NRL) using its own technology. The company owns SleepHealth, LLC and SleepHealth North Carolina, LLC (SleepHealth), privately-held sleep diagnostic companies headquartered in Monroe, Georgia. SleepHealth provides sleep lab management services to physicians’ offices, specialty and multi-specialty clinics in Georgia, North Carolina, and South Carolina. The company’s Vytex Division focuses on expanding the licensing and utilization of its proprietary source natural rubber latex technology. Its SleepHealth Division focuses on the sleep diagnostic and durable medical equipment businesses. Products and Services Natural Rubber Latex The company’s initial product portfolio included Vytex NRL in high ammonia and low ammonia formulations. The company has used its technology to work with customers to solve production issues and provide them with a point of difference. Vytex NRL is produced at the latex processor level and can be integrated into the processing environments without additional capital equipment investment. The company has a toll manufacturing agreement with Revertex (Malaysia), the producer of prevulcanized natural rubber lattices. It also has a toll manufacturing agreement with Mardec-Yala (Thailand). The company has a licensing agreement with Pica de Hule Natural, a division of GrupoAgroindustrialOccidente (Occidente), located in Guatemala. Occidente is the processor of natural rubber latex in Latin America and the exporter serving approximately 15 countries. Under the agreement, Occidente would manufacture, sell and market Vytex NRL throughout Latin America, as well as supply Vytex NRL to North America and Europe through its existing distribution system. The distributor for North America and Europe purchases and sells Vytex NRL for specific orders in their territory and does not purchase inventory to hold. The company has a licensing agreement with KA Prevulcanized Latex to manufacture and sell Vytex NRL in the SAARC region, which includes India, Pakistan, Sri Lanka, Bangladesh, Bhutan, and Nepal. The company has a distribution agreement with Centrotrade Minerals & Metals, Inc. and Centrotrade Deutschland, GmbH, the global distributors of latex raw materials, to create a worldwide distribution network. The company has agreement with Centrotrade Minerals & Metals, Inc. to expand Vytex NRL distribution rights to the NRL consuming markets in Southeast Asia, specifically Malaysia and Thailand. Sleep Diagnostics and Durable Medical Equipment SleepHealth offers physicians and multi-specialty clinics tailored programs and joint venture opportunities to manage their patients’ sleep disorders. The company provides the durable medical equipment that may be prescribed to the patient. As of December 31, 2012, the company operated and managed 21 sleep centers in its clients’ existing office space or clinic. As of March 31, 2013, the company operated 16 sleep centers. Intellectual Property The company has four issued patents by the United States Patent Trademark Office (USPTO). International patents include one issued patent from the Republic of South Africa (2008/00886), a second foreign patent issued by China (No. 200580051526.1), a third foreign patent (No. 4944885) and a fourth foreign patent issued by Hong Kong (HK1125959). In 2005, the company sought international patent protection of its application that would become its U.S. Patent No. 6,906,126 pursuant to the Patent Cooperation Treaty (PCT) (No. PCT/US2005/025018), and this application has been nationalized in the following countries and regions: The European Union (No.05775523.3), Canada (No. 2,614,945), India (No.295/DELNP/2008), and Sri Lanka (No.14827). Additionally, this PCT was nationalized back into the United States to expand the company’s protection to both method and composition claims (No.11/988,498). In 2012, the company converted the provisional patent (No. 61/433,853) to full utility applications based on new discoveries and unexpected results (No. 13/374,851). The company filed and has received registered trademark protected status in the United States for the marks Vystar, Vytex, and Created by Nature. Recreated by Science. In 2010, the company filed for international trademark protection of Vytex in Malaysia (No.2010013149) and India (No. 1992991), which was granted in India. Government Regulation The company’s business is subject to extensive federal, state and local regulation including the Health Insurance Portability and Accountability Act, Health Information Technology for Economic and Clinical Health Act, the Affordable Care Act, and the Fair Debt Collection Practices Act relating to, among other things, licensure, conduct of operations, privacy of patient information, physician relationships, addition of facilities and services, reimbursement rates for services, and consumer debt collections. History Vystar Corporation was founded in 2000. The company, a Georgia corporation, was incorporated in 2003.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VYST:US $0.10 USD -0.0099

VYST Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for VYST.
View Industry Companies

Industry Analysis


Industry Average

Valuation VYST Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 3.4x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 2.0x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VYSTAR CORP, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at